Skip to main content
3B BlackBio Dx Limited logo

3B BlackBio Dx Limited — Investor Relations & Filings

Ticker · 3BBLACKBIO ISIN · INE994E01018 LEI · 335800KC7FWKANBG5H56 BSE.NS Manufacturing
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-05-30 Report Publication Anno…
Country IN India
Listing BSE.NS 3BBLACKBIO

About 3B BlackBio Dx Limited

https://3bblackbio.com/

3B BlackBio Dx Limited specializes in the development, manufacturing, and commercialization of advanced molecular diagnostic kits. Operating under the flagship brand TRUPC®, the company provides a comprehensive portfolio of real-time PCR-based assays for oncology, infectious diseases, and human genetics. Key offerings include kits for BCR-ABL quantification, JAK2 mutation detection, and various viral load monitoring tools for HBV, HCV, and HIV. The company is recognized for its development of RT-PCR kits for COVID-19 and H1N1. Its products are designed for high sensitivity and specificity, catering to clinical laboratories and hospitals. 3B BlackBio Dx Limited maintains ISO 13485 certification, ensuring international quality standards in its production processes. The firm focuses on delivering reliable, cost-effective diagnostic solutions to improve patient management and clinical outcomes.

Recent filings

Filing Released Lang Actions
Submission of Newspaper Publication
Report Publication Announcement Classification · 82% confidence The document is a letter to the stock exchange under SEBI LODR regulator rules submitting the newspaper advertisement clipping of the audited financial results. It does not contain financial data itself, but is an announcement of the publication of those results. Therefore, it is a Report Publication Announcement.
2026-05-30 English
Dividend Update
Interim / Quarterly Report Classification · 85% confidence The document is an official SEBI LODR disclosure of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, including full P&L, balance sheet, cash flow, notes, and auditor’s report. It is not merely an earnings highlight or a notice of publication but contains comprehensive financial statements for a quarterly period (and year-to-date). This matches the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-29 English
Investor''s Presentation
Investor Presentation Classification · 95% confidence The document is an extensive slide‐style presentation titled “Investor Presentation” and “Company Update” addressed to the stock exchange’s Relationship Manager. It contains forward‐looking statements, detailed financial highlights across multiple divisions, strategic priorities, outlook, and business models, typical of an investor deck. It is neither a simple earnings release nor a proxy/filing notice but a full investor presentation. Therefore, it best fits the Investor Presentation category (IP).
2026-05-29 English
Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March, 2026
Interim / Quarterly Report Classification · 82% confidence The document is a statutory filing under SEBI LODR Regulations 30 and 33 reporting the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, including full financial statements, cash flows, notes, and auditor’s report. It contains comprehensive financial data (not just highlights), is not a full Annual Report, but is the periodic financial results release—matching the definition of an Interim/Quarterly Report. FY 2026
2026-05-29 English
Outcome of Board Meeting held today i.e. 29th May, 2026
Earnings Release Classification · 65% confidence The document is a formal SEBI LODR “Outcome of Board Meeting” filing containing the company’s audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, complete with balance sheet, cash flow statement, notes and the external auditor’s report. It is not the full Annual Report (10‐K) but rather the statutory regulatory announcement of the company’s periodical financial results. This corresponds to an Earnings Release (ER) under our taxonomy. FY 2026
2026-05-29 English
Intimation of Earning Concall under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015.
Regulatory Filings Classification · 89% confidence The document is a stock exchange intimation under Regulation 30 of SEBI LODR, notifying investors and analysts about an upcoming earnings conference call. It does not include actual financial results or a presentation deck, nor is it a transcript. It is a general regulatory announcement to the exchange and therefore falls under the broad “Regulatory Filings” category (RNS).
2026-05-26 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.